{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:28:15Z","timestamp":1772756895352,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170145"],"award-info":[{"award-number":["82170145"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.leukres.2025.107922","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T06:42:26Z","timestamp":1753166546000},"page":"107922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CHK1-S, a splicing variant of CHK1, suppresses chronic myeloid leukemia"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3288-5205","authenticated-orcid":false,"given":"Hu","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanzhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2025.107922_bib1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.277.5331.1497","article-title":"Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25","volume":"277","author":"Sanchez","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.leukres.2025.107922_bib2","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1111\/febs.13387","article-title":"DNA damage control: regulation and functions of checkpoint kinase 1","volume":"282","author":"Smits","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.leukres.2025.107922_bib3","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1101\/gad.14.12.1448","article-title":"Chk1 is an essential kinase that is regulated by Atr and required for the G(2)\/M DNA damage checkpoint","volume":"14","author":"Liu","year":"2000","journal-title":"Gene Dev."},{"key":"10.1016\/j.leukres.2025.107922_bib4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1101\/gad.14.12.1439","article-title":"Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-\/-) mice","volume":"14","author":"Takai","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.leukres.2025.107922_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1073\/pnas.1104767109","article-title":"Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints","volume":"109","author":"Pabla","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.leukres.2025.107922_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102026","article-title":"ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias","volume":"88","author":"Boudny","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.leukres.2025.107922_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.leukres.2017.11.007","article-title":"Chk1 inhibitors overcome imatinib resistance in chronic myeloid leukemia cells","volume":"64","author":"Lei","year":"2018","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2025.107922_bib8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/13543784.2019.1694661","article-title":"Investigational CHK1 inhibitors in early phase clinical trials for the treatment of cancer","volume":"28","author":"Dent","year":"2019","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.leukres.2025.107922_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20259-0","article-title":"Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem\/progenitor cells in chronic myelogenous leukemia","volume":"12","author":"Lei","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2025.107922_bib10","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1038\/ncomms5760","article-title":"Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons","volume":"5","author":"Best","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2025.107922_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.radonc.2017.09.043","article-title":"ATR\/CHK1 inhibitors and cancer therapy","volume":"126","author":"Qiu","year":"2018","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.leukres.2025.107922_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.leukres.2018.08.003","article-title":"Targeting acute myeloid leukemia CD34(+) stem\/progenitor cells with small molecule inhibitor MK-8776","volume":"72","author":"Lei","year":"2018","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2025.107922_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"da Costa","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.leukres.2025.107922_bib14","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.7150\/jca.39443","article-title":"Clinical and functional significance of CHK1-S, an alternatively spliced isoform of the CHK1 gene, in hepatocellular carcinoma","volume":"11","author":"Hu","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.leukres.2025.107922_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nm.4165","article-title":"Therapeutic targeting of splicing in cancer","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.leukres.2025.107922_bib16","article-title":"The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2025.107922_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/15384101.2022.2111769","article-title":"Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells","volume":"22","author":"Zhao","year":"2023","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2025.107922_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/sj.leu.2403310","article-title":"p210BCR\/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells","volume":"18","author":"Salesse","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2025.107922_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15516","article-title":"TRA2: The dominant power of alternative splicing in tumors","volume":"9","author":"Xue","year":"2023","journal-title":"Heliyon"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625002826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625002826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:50:33Z","timestamp":1772754633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625002826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":19,"alternative-id":["S0145212625002826"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107922","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CHK1-S, a splicing variant of CHK1, suppresses chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107922"}}